(firstQuint)BNP (Nesiritide) vs.

 Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.

.

 This is a randomized, double-blind, placebo controlled study of low dose nesiritide to prevent renal insufficiency after cardiopulmonary bypass surgery.

 Patients included are those with greater than mild renal insufficiency preoperatively as defined by having a creatinine clearance of less than 50 mL/minute determined by the Cockroft-Gault formula.

 The infusion of nesiritide (BNP) 0.

005 mcg/Kg/minute or placebo begins 1 hour before surgery and runs for 24 hours started after the induction of anesthesia prior to cardiopulmonary bypass.

.

 BNP (Nesiritide) vs.

 Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.

@highlight

Use of BNP (nesiritide) vs placebo to help protect kidney function in patients undergoing heart bypass surgery.

